(Q34001502)

English

Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β I

scientific article

Statements

Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β I (English)
Lloyd Paul Aiello
Louis Vignati
Matthew J Sheetz
Matthew D Davis
Anne M Wolka
Nazila Shahri
Roy C Milton
PKC-DRS and PKC-DRS2 Study Groups
1 November 2011
2084-2094

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit